Pivotal Role of Signal-Transducing Adaptor Protein-2 in Pathogenesis of Autoimmune Hepatitis.


Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2021
Historique:
entrez: 2 12 2021
pubmed: 3 12 2021
medline: 1 2 2022
Statut: ppublish

Résumé

Signal-transducing adaptor protein-2 (STAP-2) is an adaptor protein involved in inflammatory and immune responses, such as inflammatory bowel disease and allergic responses. In this study, we investigated the role of STAP-2 in the pathogenesis of autoimmune hepatitis. After intravenous injection of concanavalin A (ConA), STAP-2 knock out (KO) mice showed more severe liver necrosis along with substantial lymphocyte infiltration compared to wild type (WT) mice. Serum alanine aminotransferase levels were significantly higher in ConA-injected STAP-2 KO mice than in WT mice. Levels of interferon-γ (IFN-γ), an important factor for liver necrosis, were also significantly increased in sera of STAP-2 KO mice compared to WT mice after ConA injection. Statistically significant upregulation of Fas ligand (FasL) expression was observed in the livers of ConA-injected STAP-2 KO mice compared to WT mice. In accordance with these results, apoptotic signals were facilitated in STAP-2 KO mice compared to WT mice after ConA injection. Correctively, these results suggest that STAP-2 is involved in the pathogenesis of autoimmune hepatitis by regulating the expression of FasL and the production of IFN-γ.

Identifiants

pubmed: 34853275
doi: 10.1248/bpb.b21-00595
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Fas Ligand Protein 0
STAP2 protein, mouse 0
Concanavalin A 11028-71-0
Interferon-gamma 82115-62-6
Caspase 3 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1898-1901

Auteurs

Yuto Sasaki (Y)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Kodai Saitoh (K)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Kota Kagohashi (K)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Yuichi Kitai (Y)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Ryuta Muromoto (R)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Kenji Oritani (K)

Department of Hematology, International University of Health and Welfare.

Jun-Ichi Kashiwakura (JI)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Tadashi Matsuda (T)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH